UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023

Expert review of pharmacoeconomics & outcomes research, 2024-06, Vol.24 (5), p.577-579

2024

Volltextzugriff (PDF)

Economic benefits of BIS-aided assessment of post-BC lymphedema in the United States

The American journal of managed care, 2012-05, Vol.18 (5), p.234-241

2012

Volltextzugriff (PDF)

Treatment Patterns & Health Care Costs Among Patients With Stroke & Spasticity

The American journal of occupational therapy, 2023-07, Vol.77 (Supplement_2), p.7711510241-7711510241p1

2023

Volltextzugriff (PDF)

GROWTH TRAJECTORIES OF CHILDREN AND ADOLESCENTS WITH ADHD TREATED WITH DELAYED-RELEASE/EXTENDED-RELEASE METHYLPHENIDATE (JORNAY PM®): A PILOT STUDY OF REAL-WORLD DATA FROM A LARGE US CLAIMS DATABASE

Journal of the American Academy of Child and Adolescent Psychiatry, 2022-10, Vol.61 (10), p.S274-S274

2022

Volltextzugriff (PDF)

Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US

Advances in therapy, 2023-09, Vol.40 (9), p.3986-4003

2023

Volltextzugriff (PDF)

Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program

Expert review of pharmacoeconomics & outcomes research, 2024-09, Vol.24 (7), p.829-843

2024

Volltextzugriff (PDF)

Infections in secondary immunodeficiency patients treated with Privigen® or Hizentra®: a retrospective US administrative claims study in patients with hematological malignancies

Leukemia & lymphoma, 2021-12, Vol.62 (14), p.3463-3473

2021

Volltextzugriff (PDF)

Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies

Leukemia & lymphoma, 2022-01, Vol.63 (1), p.64-73

2022

Volltextzugriff (PDF)

Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolism

Journal of managed care & specialty pharmacy, 2024-05, Vol.30 (5), p.441-455

2024

Volltextzugriff (PDF)

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data

Vaccine, 2024-02, Vol.42 (5), p.1094-1107

2024

Volltextzugriff (PDF)

Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA

Journal of comparative effectiveness research, 2022-12, Vol.11 (17), p.1293-1308

2022

Volltextzugriff (PDF)

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S29-S30

2020

Volltextzugriff (PDF)

1341. Relative Vaccine Effectiveness Against Influenza-related Hospitalizations and Respiratory Events During the 2019/20 Influenza seAson in U.S. Children and Adults. A Real-World Evidence Comparison Between Quadrivalent Cell-based and Egg-based Influenza Vaccines

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S758-S758

2021

Volltextzugriff (PDF)

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S136-S136

2021

Volltextzugriff (PDF)

96. Relative Vaccine Effectiveness Against Influenza-Related and Any Respiratory-Related Hospital Encounter During the 2019/20 High Influenza Activity Period: A Comprehensive Real-World Analysis to Compare Quadrivalent Cell-based and Egg-based Influenza Vaccines

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S61-S61

2021

Volltextzugriff (PDF)

1631. Background Incidence Rates of Health Outcomes Relevant to Vaccine Monitoring in Lyme Disease Endemic and Non-endemic US Regions using Administrative Claims Data

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S38-S39

2020

Volltextzugriff (PDF)

6. MF59 ASSURANCE 2: A Real-world Study to Estimate the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-based Trivalent High-dose Among U.S. Older Adults During 2018–19 Influenza Season

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S3-S3

2020

Volltextzugriff (PDF)

Hospital providers: the day after FDA approval

Biotechnology healthcare, 2005-08, Vol.2 (4), p.58-61

2005

Volltextzugriff (PDF)

HREELS, XPS and in-situ friction studies of thin polyphenyl ether films on steel surfaces

Applied surface science, 1991-11, Vol.52 (3), p.215-226

1991

Volltextzugriff (PDF)

Characterization of Polymers and Their Surfaces Using Ultra-Soft X-Ray Absorption Spectroscopy

MRS proceedings, 1993, Vol.304, Article 215

1993

Volltextzugriff (PDF)

Ultra-Soft X-Ray Absorption Spectroscopy: A Bulk and Surface Probe of Materials

MRS proceedings, 1993, Vol.307, Article 101

1993

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(14)

Publikationsform

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023

Economic benefits of BIS-aided assessment of post-BC lymphedema in the United States

Treatment Patterns & Health Care Costs Among Patients With Stroke & Spasticity

GROWTH TRAJECTORIES OF CHILDREN AND ADOLESCENTS WITH ADHD TREATED WITH DELAYED-RELEASE/EXTENDED-RELEASE METHYLPHENIDATE (JORNAY PM®): A PILOT STUDY OF REAL-WORLD DATA FROM A LARGE US CLAIMS DATABASE

Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US

Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program

Infections in secondary immunodeficiency patients treated with Privigen® or Hizentra®: a retrospective US administrative claims study in patients with hematological malignancies

Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies

Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolism

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data

Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly

1341. Relative Vaccine Effectiveness Against Influenza-related Hospitalizations and Respiratory Events During the 2019/20 Influenza seAson in U.S. Children and Adults. A Real-World Evidence Comparison Between Quadrivalent Cell-based and Egg-based Influenza Vaccines

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season

96. Relative Vaccine Effectiveness Against Influenza-Related and Any Respiratory-Related Hospital Encounter During the 2019/20 High Influenza Activity Period: A Comprehensive Real-World Analysis to Compare Quadrivalent Cell-based and Egg-based Influenza Vaccines

1631. Background Incidence Rates of Health Outcomes Relevant to Vaccine Monitoring in Lyme Disease Endemic and Non-endemic US Regions using Administrative Claims Data

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season

6. MF59 ASSURANCE 2: A Real-world Study to Estimate the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-based Trivalent High-dose Among U.S. Older Adults During 2018–19 Influenza Season

Hospital providers: the day after FDA approval

HREELS, XPS and in-situ friction studies of thin polyphenyl ether films on steel surfaces

Characterization of Polymers and Their Surfaces Using Ultra-Soft X-Ray Absorption Spectroscopy

Ultra-Soft X-Ray Absorption Spectroscopy: A Bulk and Surface Probe of Materials

Suchergebnisse filtern